Kite Pharma, Inc. Debt Instrument, Convertible, Conversion Price
Kite Pharma, Inc. had Debt Instrument, Convertible, Conversion Price of $2.61 per share as of 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Notes
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2015-03-26
- 2014-12-31: Debt Instrument, Convertible, Conversion Price $2.61.
- 2014-09-30: Debt Instrument, Convertible, Conversion Price $2.61.
- 2014-06-30: Debt Instrument, Convertible, Conversion Price $2.61.
- 2013-05-15: Debt Instrument, Convertible, Conversion Price $1.31.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2014-12-31 | $2.61 10-K · filed 2015-03-26 |
| 2014-09-30 | $2.61 10-Q · filed 2014-11-14 |
| 2014-06-30 | $2.61 10-Q · filed 2014-08-14 |
| 2013-05-15 | $1.31 10-K · filed 2015-03-26 |